» Articles » PMID: 35314697

Transcriptional Analysis of Peripheral Memory T Cells Reveals Parkinson's Disease-specific Gene Signatures

Abstract

Parkinson's disease (PD) is a multi-stage neurodegenerative disorder with largely unknown etiology. Recent findings have identified PD-associated autoimmune features including roles for T cells. To further characterize the role of T cells in PD, we performed RNA sequencing on PBMC and peripheral CD4 and CD8 memory T cell subsets derived from PD patients and age-matched healthy controls. When the groups were stratified by their T cell responsiveness to alpha-synuclein (α-syn) as a proxy for an ongoing inflammatory autoimmune response, the study revealed a broad differential gene expression profile in memory T cell subsets and a specific PD associated gene signature. We identified significant enrichment of transcriptomic signatures previously associated with PD, including for oxidative stress, phosphorylation, autophagy of mitochondria, cholesterol metabolism and inflammation, and the chemokine signaling proteins CX3CR1, CCR5, and CCR1. In addition, we identified genes in these peripheral cells that have previously been shown to be involved in PD pathogenesis and expressed in neurons, such as LRRK2, LAMP3, and aquaporin. Together, these findings suggest that features of circulating T cells with α-syn-specific responses in PD patients provide insights into the interactive processes that occur during PD pathogenesis and suggest potential intervention targets.

Citing Articles

Exploring the underlying molecular connections: a bioinformatics approach to link melanoma and Parkinson's disease.

Zhang L, Li D, Zheng X, Wu M, Yao Q, Chen H Front Genet. 2025; 16:1526018.

PMID: 40066251 PMC: 11891206. DOI: 10.3389/fgene.2025.1526018.


A single-cell atlas to map sex-specific gene-expression changes in blood upon neurodegeneration.

Grandke F, Fehlmann T, Kern F, Gate D, Wolff T, Leventhal O Nat Commun. 2025; 16(1):1965.

PMID: 40000636 PMC: 11862118. DOI: 10.1038/s41467-025-56833-7.


Combining Single-Cell RNA Sequencing and Mendelian Randomization to Explore Novel Drug Targets for Parkinson's Disease.

Wu X, Wang K, Li Q, Zhang Y, Wei P, Shan Y Mol Neurobiol. 2025; .

PMID: 39890696 DOI: 10.1007/s12035-025-04700-3.


PINK1 is a target of T cell responses in Parkinson's disease.

Williams G, Freuchet A, Michaelis T, Frazier A, Tran N, Rodrigues Lima-Junior J J Clin Invest. 2024; 135(4).

PMID: 39688918 PMC: 11827839. DOI: 10.1172/JCI180478.


Potential correlation between chronic periodontitis and Parkinson's disease.

Yang R, Zong Y, Zhang C Hua Xi Kou Qiang Yi Xue Za Zhi. 2024; 42(4):521-530.

PMID: 39049641 PMC: 11338491. DOI: 10.7518/hxkq.2024.2024010.


References
1.
Yavich L, Jakala P, Tanila H . Abnormal compartmentalization of norepinephrine in mouse dentate gyrus in alpha-synuclein knockout and A30P transgenic mice. J Neurochem. 2006; 99(3):724-32. DOI: 10.1111/j.1471-4159.2006.04098.x. View

2.
Dobin A, Davis C, Schlesinger F, Drenkow J, Zaleski C, Jha S . STAR: ultrafast universal RNA-seq aligner. Bioinformatics. 2012; 29(1):15-21. PMC: 3530905. DOI: 10.1093/bioinformatics/bts635. View

3.
Postuma R, Berg D . Advances in markers of prodromal Parkinson disease. Nat Rev Neurol. 2016; 12(11):622-634. DOI: 10.1038/nrneurol.2016.152. View

4.
Di Maio R, Hoffman E, Rocha E, Keeney M, Sanders L, De Miranda B . LRRK2 activation in idiopathic Parkinson's disease. Sci Transl Med. 2018; 10(451). PMC: 6344941. DOI: 10.1126/scitranslmed.aar5429. View

5.
Archibald N, Miller N, Rochester L . Neurorehabilitation in Parkinson disease. Handb Clin Neurol. 2013; 110:435-42. DOI: 10.1016/B978-0-444-52901-5.00037-X. View